Sanofi
Fused Pentacyclic Imidazole Derivatives as Modulators of TNF Activity

Last updated:

Abstract:

A compound of formula (I) as defined herein, or a pharmaceutically acceptable salt thereof, being potent modulators of human TNF.alpha. activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders; neurological and neurodegenerative disorders; pain and nociceptive disorders; cardiovascular disorders; metabolic disorders; ocular disorders; and oncological disorders.

Status:
Application
Type:

Utility

Filling date:

15 Feb 2021

Issue date:

19 Aug 2021